121 related articles for article (PubMed ID: 13170253)
1. [Additional occurrence of carcinoma in a malignant disease treated with triethylene melamine].
LUHRS W; SCHAMMEL J; LOTZ HH
Z Gesamte Inn Med; 1954 Mar; 9(6):295-9. PubMed ID: 13170253
[No Abstract] [Full Text] [Related]
2. [Clinical trials with triethylene melamine].
FERRARI M; KASDORF H
Arch Urug Med Cir Espec; 1953; 42(3-4):134-44. PubMed ID: 14350952
[No Abstract] [Full Text] [Related]
3. Triethylene melamine (TEM) in the treatment of malignant lymphoid disease.
HAMBLY CK; ROBERTSON TI
Med J Aust; 1955 Jun; 42(1 25):900-11. PubMed ID: 13243982
[No Abstract] [Full Text] [Related]
4. [Thirty cases of chronic leukemic lymphadenosis treated with intravenous administration of triethylene melamine].
GIGANTE D; ZOPPINI A
Prog Med (Napoli); 1956 Jun; 12(12):361-8. PubMed ID: 13350408
[No Abstract] [Full Text] [Related]
5. Some clinical experience in the use of triethylene melamine (TEM).
HAMERMAN DJ; MELAMED S
J Mt Sinai Hosp N Y; 1953; 20(1):16-26. PubMed ID: 13061942
[No Abstract] [Full Text] [Related]
6. Triethylene melamine in the treatment of neoplastic disease.
RUNDLES RW; BARTON WB
Blood; 1952 May; 7(5):483-507. PubMed ID: 14925143
[No Abstract] [Full Text] [Related]
7. [Triethylenemelamine (TEM) in lymphatic leukemia].
PRIBILLA W; STOLLBERG G
Munch Med Wochenschr; 1954 Oct; 96(41):1189-91. PubMed ID: 13223716
[No Abstract] [Full Text] [Related]
8. The immediate action of triethylene melamine in chronic lymphatic leuchaemia.
BOLTON JH; BEAN RH
Med J Aust; 1954 Sep; 2(12):474-8. PubMed ID: 13213377
[No Abstract] [Full Text] [Related]
9. [Treatment of hemoblastosis with triethylene melamine].
LINKE A; LASCH HG
Dtsch Med Wochenschr; 1953 Jun; 78(25):911-6. PubMed ID: 13068032
[No Abstract] [Full Text] [Related]
10. The clinical use of triethylene melamine.
KRAVITZ SC; DIAMOND HD; CRAVER LF
Blood; 1952 Jul; 7(7):729-42. PubMed ID: 14934758
[No Abstract] [Full Text] [Related]
11. [Fatal uremia after triethylenemelamine treatment in chronic lymphatic leukemia].
MARTIN H
Klin Wochenschr; 1953 Mar; 31(11-12):263-6. PubMed ID: 13070457
[No Abstract] [Full Text] [Related]
12. [Our experience with the application of triethylene melamine (TEM) in patients with malignant hemopathies].
RUVIDIC R; NIKOLIC J
Med Glas; 1960 Sep; 14():435-42. PubMed ID: 13744964
[No Abstract] [Full Text] [Related]
13. [Therapy of malignant diseases with triethylene melamine].
ROMEO ORBEGOZO JM
Rev Clin Esp; 1953 Sep; 50(5):382-6. PubMed ID: 13134813
[No Abstract] [Full Text] [Related]
14. Results in the use of triethylene melamine (TEM) in malignant lymphomas and chronic leukemias.
MEZA ARRAU C; NIJAMKIN A
Rev Med Chil; 1955 Feb; 83(2):90-5. PubMed ID: 14385308
[No Abstract] [Full Text] [Related]
15. Triethylene melamine (TEM) therapy in malignant diseases.
RUNDLES RW
GP; 1954 May; 9(5):75-80. PubMed ID: 13151309
[No Abstract] [Full Text] [Related]
16. TRIETHYLENE-MELAMINE.
Br Med J; 1955 Jun; 1(4926):1380-1. PubMed ID: 14363905
[No Abstract] [Full Text] [Related]
17. [Triethylene melamine therapy of leukemia and lymphogranulomatosis].
MILIC N
Lijec Vjesn; 1954; 76(1-2):40-6. PubMed ID: 13175578
[No Abstract] [Full Text] [Related]
18. [Considerations on a case of leukosarcomatosis].
FUSCO FA
Arch Maragliano Patol Clin; 1956 Jun; 12(3):499-532. PubMed ID: 13363614
[No Abstract] [Full Text] [Related]
19. [Triethylene melamine treatment of leukemia and lymphogranulomatosis].
CAKMAKCI A
Turk Tip Cemiy Mecm; 1954 Jun; 20(6):290-314. PubMed ID: 13217043
[No Abstract] [Full Text] [Related]
20. [Clinical experiences with triethylene melamine in therapy of neoplastic diseases of the blood].
BOCK HE; KIRBERGER E; WOELFFER U
Z Klin Med; 1953; 150(5):482-98. PubMed ID: 13137291
[No Abstract] [Full Text] [Related]
[Next] [New Search]
